Matthew J Koch
Affiliation: Washington University School of Medicine
- Considerations in retransplantation of the failed renal allograft recipientMatthew J Koch
Department of Medicine, Washington University School of Medicine at Barnes Jewish Hospital, St Louis, MO 63110, USA
Adv Chronic Kidney Dis 13:18-28. 2006..This review discusses available data and individual considerations that should be taken into account when retransplantation is proposed after failure of a primary allograft...
- Cyclosporine minimization and cost reduction in renal transplant recipients receiving a C2-monitored, cyclosporine-based quadruple immunosuppressive regimenKaren L Hardinger
Department of Pharmacy, Barnes Jewish Hospital, Washington University, One Barnes Jewish Hospital Plaza, St Louis, MO 63110, USA
Transplantation 78:1198-203. 2004..This trial determines whether lower C2 levels could be targeted safely in de novo kidney transplant recipients under a quadruple regimen compared with a similar cohort monitored with trough (C0) levels...
- Thymoglobulin induction is safe and effective in live-donor renal transplantation: a single center experienceKaren L Hardinger
Department of Pharmacy Practice, University of Missouri Kansas City, Kansas City, MO 64108 2792, and Department of Medicine, Barnes Jewish Hospital at Washington University School of Medicine, St Louis, MO, USA
Transplantation 81:1285-9. 2006..This paper presents observational data of live-donor recipients who received Thymoglobulin induction and standard maintenance immunosuppressive therapy...
- Serum sickness after treatment with rabbit antithymocyte globulin in kidney transplant recipients with previous rabbit exposureRaghavender Boothpur
Barnes Jewish Hospital, St Louis, MO, USA
Am J Kidney Dis 55:141-3. 2010..Jaw pain appears to be a hallmark symptom, and treatment with plasmapheresis and steroids relieves symptoms more rapidly than steroids alone...
- Current and future immunosuppressive strategies in renal transplantationKaren L Hardinger
Department of Pharmacy, Barnes Jewish Hospital, Washington University School of Medicine, St Louis, Missouri 63110, USA
Pharmacotherapy 24:1159-76. 2004..Allograft tolerance and xenotransplantation are being studied, and the knowledge gained from the effort may help in the development of innovative strategies and new immunosuppressive agents...
- Five-year follow up of thymoglobulin versus ATGAM induction in adult renal transplantationKaren L Hardinger
Department of Pharmacy, Washington University School of Medicine, St Louis, MO, USA
Transplantation 78:136-41. 2004..63%), less acute rejection (4% vs. 25%), and better graft survival. This article compares the safety and efficacy of Thymoglobulin versus Atgam induction through 5 years...
- Pharmacokinetics of tacrolimus in kidney transplant recipients: twice daily versus once daily dosingKaren L Hardinger
Department of Pharmacy, Barnes Jewish Hospital at Washington University, St Louis, MO, USA
Am J Transplant 4:621-5. 2004..Tacrolimus given once daily in the morning, at 85% of the twice daily dose, provides safe and equivalent drug exposure to twice daily dosing. This convenient dosing schedule may help to increase compliance and lower costs...